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Dengue virus (DENV) genome includes a polycistronic gene coding for the structural 
and non-structural proteins and two untranslated regions (UTR) at the 3’ and 5’ ends. 
Recently, there has been an increased interest in the 3’ UTR following the discovery 
of a fragment from this region that is refractory to degradation by host exonucleases 
and remains in the cell – called subgenomic flavivirus RNA (sfRNA). We examined 
DENV-2 strains isolated during the 1994 epidemic in Puerto Rico and found that 
substitutions in the 3’ UTR altered viral fitness through the production of sfRNA, 
which seems to inhibit interferon expression by interfering with the RIG-I pathway. 
To gain insights on how sequence differences in the 3’UTR impact DENV viral 
fitness, we applied a RNA phylogeny approach to estimate the level of conservation 
and establish the dynamic of evolution of the RNA structures in the 3’ UTR. These 
data showed that presence of some structures and the length of the 3’ UTR differs 
among the four DENV serotypes. A region immediately downstream of the stop 
codon in NS5 was found to be highly variable across and within serotypes in term of 
composition and length, even tolerating multiple nucleotides deletions. Furthermore, 
positive selection was identified in a conserved RNA structure of the 3’ UTR of 
DENV-2. This analysis also identified several substitutions at the 3’ UTR that might 
be involved in similar strain replacements that have epidemiological consequences in 
the Pacific islands, Nicaragua and Singapore. Taken collectively, these data suggest 
that nucleotide substitutions in the 3’ UTR of dengue virus can have an impact in viral 
fitness, modifying the sfRNA production, its structure and protein binding properties. 
Moreover, the evolutionary analysis carried out in this study also provides a 
foundation for subsequent exploration into the significance of mutations in this region 
with respect to their effect on viral fitness and epidemic potential. 
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CHAPTER 1: INTRODUCTION 
Dengue is an acute viral infection caused by four genetically related positive sense 
single-stranded RNA viruses in the family Flaviviridae. Although most dengue virus 
(DENV) infections are benign, these viruses cause more than half a million severe 
cases annually (WHO. 2013). The molecular basis for the development of severe 
forms of dengue is not fully understood but it has been associated with secondary 
infections with one of the four heterologous serotypes. It is postulated that the 
production of antibodies against a given serotype facilitates the entry of the remaining 
three DENV serotypes into the host cells through Fc receptor mediated endocytosis 
and thus amplifying the virus replication (Halstead SB et al. 1977). Therefore, if a 
population has low immunity and has been previously exposed to DENV, the 
introduction of a different serotype could enhance viral infection and result in a higher 
rate of severe dengue. However, not all serotype changes has resulted in epidemics. 
Instead, emergence of new strains within the same serotype has led to epidemics. For 
instance, a DENV serotype 2 strain emerged in Puerto Rico in 1994 during an 
outbreak and replaced another DENV-2 strain that had been endemic in the island for 
at least 10 years (McElRoy KL et al. 2011). This instance, along with other published 
epidemiological observations; indicates that factors other than low herd immunity or 
heterotypic immunity alone determine epidemic potential.   
In our laboratory, we examined DENV-2 isolated during the 1994 epidemic in Puerto 
Rico and found three nucleotide substitutions in the 3’ untranslated region (UTR) that 
altered viral fitness through the production of subgenomic flavivirus RNA (sfRNA), a 
genomic RNA segment that is refractory to degradation and has been implicated in 
the virus-induced pathogenicity (Piljman GP et al. 2008). Our experimental data also 
indicates that sfRNA inhibits interferon expression by binding to and interfering with 
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proteins in the RIG-I signaling pathway, suggesting that substitutions in the 3’UTR of 
dengue virus can have an impact in viral fitness, modifying the sfRNA production and 
its protein binding properties (Manokaran G. 2014). 
In the literature, nucleotide substitutions in the 3’ UTRs of dominant DENV strains 
have been reported to cause three more lineage replacements in Nicaragua, India and 
Sri Lanka (Dash PK et al. 2015, OhAinle M et al. 2011, Silva RL et al. 2008, 
respectively). However, the impact of those substitutions on viral fitness still remains 
to be determined. In addition, the lack of structural data has hindered the 
understanding of nucleotide substitutions in the 3’ UTR of dengue viruses and their 
structural consequences on DENV viral fitness. Therefore, this study aimed to provide 
the missing structural and evolutionary background to unveil the consequences of 
nucleotide substitutions in the 3’ UTR of DENV with respect to DENV 
epidemiological fitness. 
1.1 Aims of study 
1.1.1 To describe the 3’ untranslated region of the dengue viruses. 
a) To estimate the nucleotide composition, conservation and nucleotide 
distribution pattern in the DENV 3’ UTR. 
b) To solve and describe the RNA secondary structures in 3’ UTR of dengue 
viruses. 
1.1.2 To describe the evolution of 3’ untranslated region of the dengue viruses. 
a) To test natural selection in RNA structures of the DENV 3’ UTR. 
b) To describe the dynamics of evolution in the 3’ UTR of evolution. 
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1.1.3 To determine structural consequences of nucleotide substitutions in the 3’ 
UTR of DENV and their impact on epidemiological fitness. 
a) To describe the structural consequences associated to nucleotide differences in 
the 3’ UTR of the two DENV-2 lineages involved in the 1994 Puerto Rico 


















CHAPTER 2: LITERATURE REVIEW 
2. 1. Background on Dengue 
2.1.1. The causative agent 
Dengue viruses are positive sense single-stranded RNA (ssRNA) viruses in the family 
Flaviviridae. The four dengue virus serotypes are grouped within the flavivirus genus 
together with West Nile virus (WNV), Japanese encephalitis virus (JEV), Tick-borne 
encephalitis virus (TBEV), Murray Valley encephalitis virus (MVEV), St Louis 
encephalitis virus (SLEV) and yellow fever virus (YFV). Their approximately 11kb 
genome (Fig. 1) has highly functional and essential 5’ and 3’ untranslated regions 
(UTR) and an open reading frame (ORF) that codes a single polyprotein that is 
processed into three structural proteins; capsid (C), pre-membrane (prM) and the 
envelope (E) proteins, as well as into seven non-structural (NS) proteins (NS1, NS2A, 
NS2B, NS3, NS4A, NS4B, NS5) (Reviewed by Gebhard LG et al. 2011, Perera R & 





Figure 1. Schematic representation of the dengue virus genome. Untranslated 
regions are represented by structured lines and the genes encoded by the Open 
Reading Frame are shown as boxes. Red line and green interrupted line represent 
long range RNA-RNA interactions that mediate the cyclization of the DENV 
genome during replication.   
Adapted from Gebhard LG et al. (2011) 
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The DENV structure was first determined by using cryo-electron microscopy (Cryo-
EM) and fitting into the electron density map a previously crystallized structure of the 
E glycoprotein (Kuhn RJ et al. 2002). The cryo-EM reconstruction revealed a virion 
of approximately 500 Å with a relatively smooth surface. The virion is composed of a 
well-organized outer E protein shell and an electron-dense core surrounded by a lipid 
bilayer membrane. Later studies further confirmed this structure and also revealed that 
the E protein on the surface is susceptible to structural changes under different 
temperatures (Fig. 2) and at the lower pH in the endosomes to induce membrane 
fusion and the release of the viral RNA into the cytosol (Modis Y et al. 2004, 





The DENV genome has also important RNA structures at the 5’ and 3’ UTRs (Fig. 3) 
and like many cellular mRNA, it contains a type 1 cap (m7GpppAmp) structure at the 
5’ end but lacks a poly-A tail at the 3’ end. 
The DENV 5’ UTR is around 100 nucleotides long and possesses two RNA domains 
with distinct suggested functions during genomic RNA replication (Fig. 3). The first ~ 
Adapted from Rey FA (2013) 
Figure 2. DENV type 2 structure at different temperatures.  (a) At 28 °C, mature 
dengue virus particles are composed of 90 dimers of the glycoprotein protein E and 
have icosahedral symmetry. (b) and (c) at 34 °C and above,  DENV particles take an 
expanded form, no longer adopting an icosahedral symmetry and exposing the viral 
membrane (purple).  
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70 nucleotides are predicted to form a large stem-loop structure (SL-A) – a Y shaped 
structure, which has been shown to bind the NS5 protein and serves as promoter for 
RNA synthesis (Filomatori et al. 2006). The second domain of approximately 30 
nucleotides is predicted to form a short stem-loop (SL-B) and includes an 
indispensable sequence that mediates a long-range RNA-RNA interaction required for 
genome replication, termed as 5’ upstream AUG codon region (UAR) (Yu L et al 
2008). Furthermore, immediately after the translation initiation codon, within the 
coding sequence, a stable harpin (cHP) contains a 5’ conserved sequence (5’CS) that 
is also essential for DENV RNA replication (Clyde K et al. 2008).  
  
 
The 3’UTR of DENV is approximately 450 nucleotides long and can be divided into 
three domains (Fig. 3). Domain I is located just downstream the stop codon and is 
considered the most variable region (VR) in the 3’UTR (Alvarez DE et al. 2005B). 
Domain II contains two dumbbell structures (DB1 and DB2), which are characteristic 
of the flaviviral 3’ UTRs and include two conserved sequences (CS), named as CS2 
and RCS2 (repeated CS2), respectively. As the most conserved region in the 3’ UTR, 
Domain III bears a CS1, a 14-nucleotides small hairpin (sHP) and a large stem-loop 
structure. These latter two structures are termed as 3’SL (Hahn CS et al. 1987). CS1 
mediates the long-range RNA-interaction with the 5’CS, through Watson-Crick base-
5’ UTR 3’ UTR 
Figure 3. Secondary structures at the 5’ and 3’ UTRs of dengue virus genome. 
Description is in the main text.  
Adapted from Gebhard LG et al. (2011) 
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pairing. In the 3’SL, a conserved sequence called 3’ UAR was found to base-pair with 
the 5’ UAR conserved sequence in the SL-B at the 5’ end. These two long-range 
RNA-RNA interactions (Fig. 1) lead to the cyclization of the RNA genome and are a 
conserved and required feature for DENV RNA replication (Alvarez DE et al. 
2005A). 
Despite variation in length within and across serotypes (Shurtleff AC et al. 2001), 
Domain I of the 3’ UTR has recently been found to possess an important RNA 
structure, which is resistant to degradation by the host Xrn1 ribonuclease and thus 
protects the rest of the 3’UTR RNA from degradation, thus accumulating itself in the 
cytosol as subgenomic flavivirus RNA (sfRNA) (Chapman EG et al. 2014A). The 
production of sfRNA seems to be a unique feature in the genus flavivirus (Fig. 4). It 
has also been recently suggested to play a variety of important roles, including virus-
induced pathogenicity, modulation of the host mRNA stability and inhibition of type I 
interferon response in DENV and other flavivirus infection (Pijlman GP et al. 2008, 
Schuessler A et al. 2012, Moon SL et al. 2012, Chang RY et al. 2013, Bidet K et al. 




Figure 4. Subgenomic flavivirus RNA production. A 0.3-0.5 kb subgenomic 
RNA was found to be produced only by the flavivirus genus within Flaviviridae 
family. 
Adapted from Pijlman GP et al. (2008) 
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2.1.2. Virus replication 
Several attachment factors, including cellular proteins and carbohydrates molecules, 
have been shown to provide the first point of contact between the host cell and the E 
protein of the virus, suggesting that DENV may use different receptors for cell entry 
(Tassaneetrithep B et al. 2003, Miller JL et al. 2008). These attachment factors 
concentrate the virus at the cell surface and thus allow the virus internalization 
through clathrin-mediated endocytosis (van der Schaar HM et al. 2008).  Intriguingly, 
the DENV cell entry seems to be dependent of the cell type and virus strain, as 
caveolae and lipid raft mediated endocytosis have also been reported (Reviewed in 






Figure 5. Mechanism for membrane fusion mediated by DENV E protein. (a) E 
binds to a cell surface receptor and mediates the internalization of the virion. (b) 
The low pH in the endosome triggers a conformational change in the E protein, 
exposing the fusion loop, (c) which is inserted into the cell membrane and inducing 
trimer formation. (d) Amino acid contacts spread from the tip to the root of the 
trimer and domain III rotation causes the C-terminal portion of E protein to fold 
back, thus the apposed membranes are bended by energy release during this 
refolding. (e) Additional trimer contacts lead first to hemifusion and then (f) to the 
lipidic fusion pore formation. 
Adapted from Modis Y, et al. (2004) 
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After endocytic uptake, DENV is trafficked to the early endosomes, which mature to 
late endosomes and their low-pH environment triggers a series of structural changes 
in the E protein that mediate the fusion of the viral and the endosomal membranes 
(Fig. 5). These structural changes then lead to the discharge of the nucleocapsid and 
the viral genome into the cytosol (Modis Y et al. 2004, Reviewed by Stiasny K et al. 
2011). 
Once in the cytosol, the positive sense RNA initiates a first round of translation in the 
endoplasmic reticulum (ER), where signal sequences in the polyprotein locate the 
NS1 and the ecto-domain of p-M and E proteins into its lumen and the C, NS3 and 
NS5 proteins into the cytoplasm. NS2A/B and NS4A/B remain mainly as 
transmembrane proteins. Thereafter, a combination of host enzymes in the ER lumen 
and the NS2B-NS3 complex in the cytoplasm carry out the co- and post-translational 









Figure 6. Membrane topology of the DENV polyprotein. Viral RNA is translated 
into a polyprotein and processed by cellular and viral proteases. Cleavage sites are 
denoted by arrows and their colors correspond to the protease shown in the figure. 
Adapted from Perera R & Kuhn RJ. (2008) 
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After the early translation and processing, a replication complex (RC) is formed in the 
virus-induced intracellular membrane structures, gathering together the NS3 protein 
(protease-Helicase), NS5 protein (RNA-dependent RNA polymerase and Methyl-
transferase), viral RNA and host cell factors (Miller S and Krijnse-Locker J. 2008). In 
this complex, it has been suggested that the complementary sequences in the 5’ and 3’ 
UTRs base-pair, inducing the cyclization of the RNA genome, and thus allowing the 
NS5-mediated polymerization of a full genome negative sense RNA (Alvarez DE et 
al. 2005A, Gebhard LG et al. 2011), which later serves as template for the synthesis 
of the positive sense RNA progeny – in a semi-conservative and asymmetric manner. 
The positive sense RNA is also capped at the 5’ end by the NS5 protein and released 
either to assemble into virions or to attach to ribosomes and undergo a new translation 
cycle (Bartenschlager R and Miller S. 2008). 
Although virion assembly most likely occurs in the ER, its maturation appears to take 
place in the Golgi apparatus, where the viral membrane proteins are glycosylated and 
the pre-M protein is proteolytically cleaved by furin – a Golgi-resident enzyme. Once 
the pr-fragment is removed, the E proteins form homodimers and the mature virion 
exits the cell. Interestingly, the uncleaved pr-m impedes the E proteins from 
undergoing the pH-induced changes and thus prevents premature fusion to 














2.1.3. The disease and its burden 
Dengue is the most rapidly spreading arthropod borne viral disease on earth, with an 
incidence that has increased 30 fold in the last 60 years. Areas endemic for dengue 
have also expanded, putting at risk around 40% of the human population. 
Approximately 390 million people per year are infected with any of the four dengue 
viruses causing more than 500 000 cases of severe disease which require 
hospitalization. An estimated 2.5% of those patients with severe disease die of the 
illness each year (Bhatt S, et al. 2013 and WHO, 2013). This dramatic spread of 
dengue has been associated to the discontinuation of mosquito control measures in 
many countries, the exponential growth of human population, the water and waste 
management problems related to uncontrolled urbanization and the increase in flight 
connection and population movement (Gubler DJ & Clark GG. 1998).  
While most of the human infections are asymptomatic, symptomatic infections 
present as a sudden-onset febrile illness with rash, arthralgia, myalgia, retro-orbital 
pain, headache, thrombocytopenia and leucopenia – a presentation term as dengue 
Figure 7. Cryo-EM reconstruction of the immature and mature DENV-4 
virions. The immature virion and the mature virion (Protein Data Bank: 3C6R and 
4CBF, respectively) differ by the presence of pr-fragment. It is shown in orange, 
green and white on the immature virion.  
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fever (DF). Whereas only 1-2% of the infections are followed by a more severe form 
of the disease, dengue hemorrhagic fever (DHF) and/or dengue shock syndrome 
(DSS), which is characterized by hemorrhage, increased vascular permeability, shock 
and/or plasma leakage (WHO. 2013). The pathogenesis of severe dengue disease is 
not fully understood but it is associated with pediatric populations 
(Witayathawornwong P. 2005) with prior immunity to a heterotypic DENV serotype 
from a prior infection (Halstead SB. 1970, 1979 and 1980). Other risk factors 
implicated include virus strain (Vaughn DW et al. 2000, Wang WK et al. 2003), the 
patient’s nutritional status (Kalayanarooj S et al. 2005, Thisyakorn U et al. 1993) and 
human population genetics (Nguyen TP et al. 2008, Appanna R et al. 2010).  
2.1.4. The immune response to DENV infection and its pathological and 
evolutionary consequences 
Among the above-mentioned risk factors, a prior heterotypic infection appears to play 
a crucial role in disease severity. The presence of antibodies with a limited cross-
reactivity at sub-neutralizing levels have been suggested to lead to an antigen binding 
which does not correlate with protection against a heterotypic infection. On the 
contrary, they facilitate virus entry through Fc gamma receptor mediated phagocytosis 
and amplify the virus replication in monocytes, macrophages (Halstead SB et al. 
1977) and dendritic cells (DC) (Boonnak K et al. 2008 and Marovich M et al. 2001); 
this phenomenon has been termed antibody-dependent enhancement (ADE) (Fig. 8). 
The enhanced entry of DENV in these cell types is thought to lead to increased 
replication and hence higher viremia in the early stage of infection that has been 
associated with DHF cases (Halstead SB et al. 1970, 1979 and 1980, Vaugh DW et al. 
2000, Endy TP et al. 2004). For many years, this hypothesis contrasted with findings 
from the immunology field, as the binding of the antibodies activates Fc receptor 
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signaling, which triggers an antiviral response through phosphorylation of Syk and 
Stat1 (Dhodapkar KM et al. 2007). Recent work, however, revealed that antibody-
opsonized DENV co-ligate the leukocyte Ig-like receptor-B1 to inhibit Fc gamma 
receptor signaling, reducing interferon response and enhancing DENV replication 






Besides enhancing entry, the immune response to a secondary heterotypic infection is 
thought to be dominated by cross-reactive memory B and T cell responses due to 
original antigenic sin (Rothman AL. 2011). It is hypothesized that infected-DCs 
present DENV antigens in the context of the Human Leukocyte Antigen (HLA) 
molecules to the CD4+ and CD8+ memory T cells, leading to a greater activation and 
proliferation of these cells than in a primary DENV infection.  These cells in turn 
release interferon gamma (IFN), Tumor Necrosis Factor alpha (TNF) and other 
pro-inflammatory cytokines (Mandanga MM et al. 2002), triggering a ‘cytokine 
storm’ that act on vascular endothelial cells and increasing vascular permeability and 
plasma leakage, as observed in DHF and DSS (Pang T et al. 2007). 
Although ADE of DENV infection in Fc receptor bearing cells remains as the most 
accepted mechanism for dengue severity, more recent work also suggests a role for 
other cell-types in the pathogenesis of DHF. For instance, it has been shown that mast 
Adapted from Whitehead SS et al. (2007) 
Figure 8. Antibody dependent enhancement of Dengue virus infection.  
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cells (MC) are activated and release vaso-active products during in vivo DENV 
infection (St John AL et al. 2013). Furthermore, studies using MC-deficient mice also 
showed that their activation substantially limits DENV infection at the early skin 
infection site (St John AL et al. 2011). Conversely, during a systemic DENV 
infection, MC activation and degranulation seem to be deleterious and further 
enhanced during a secondary DENV infection. Since ADE appears to be also possible 
in MCs as a consequence of the uptake of antibodies-virus complexes through Fc 





Figure 9. Temperature over time in human secondary DENV infections. Charts 
M to T represent body temperature over time of 8 different volunteers who 
experienced experimental secondary heterotypic DENV infection at least 4 month 
after primary infection. Solid lines represent temperature in primary infection. 
Dotted lines represent secondary infection. Only one (S) of the volunteers did not 
have a shorter incubation period in the secondary heterotypic infection. 
Adapted from Snow GE 
et al. (2014) 
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Despite most of the data that support the different proposed mechanisms behind the 
association between a heterotypic secondary infection and dengue severity are from in 
vitro studies and animal models that do not fully reproduce a human infection, ADE 
DENV infection remains as the most accepted hypothesis. Singularly, experimental 
human infections were performed as an effort to develop a vaccine during the Second 
World War (Sabin AB. 1952). The notes and data from these experiments were 
recently revisited (Fig. 9) (Snow GE et al. 2014) and revealed that people inoculated 
with a heterologous serotype at 4 months or longer after the primary infection had a 
shorter incubation period compared with primary infection, endorsing the prevailing 
role of the immune enhancement in DENV infections. 
The existence of four serotypes and their immune enhancement has also important 
implications on their evolution; ADE may facilitate the spread of the viruses in the 
current sympatric distribution and supports the hypothesis that DENV evolved 
independently in an allopathic distribution from different sylvatic progenitors 
(Holmes EC & Twiddy SS. 2003). In an allopatric distribution these viruses might 
have experienced different evolutionary pressures in their within-host and interspecies 
transmission and it could have allowed the antigenic divergence to occur and drive the 
emergence of the different serotypes. In addition, the RNA-dependent RNA 
polymerase of DENV has no proof-reading capacity (Steinhauer DA et al. 1992) and 
produces approximately one mutation per round of genome replication (Drake JW et 
al. 1993), which may have further favored the evolution and emergence of 




Moreover, after the establishment of larger human urban population and vector 
density, these antigenically divergent serotypes may still be selected due to the lack of 
a cross protective immune response and the amplifying effect of immune 
enhancement, contributing to the spread of the virus in the human population and the 
maintenance of the DENV antigenic and genetic diversity (Holmes EC & Burch SS, 
2000). Hence, DENV have become very successful at exploiting human and mosquito 
behaviors to establish a human-mosquito cycle and spread around the globe, 
becoming a preeminent arthropod borne disease in humans (Gubler DJ &Clark GG. 
1995). 
Despite these favorable conditions for DENV spread, DENV evolution has important 
molecular constraints due to the need to replicate in at least 2 species and the distinct 
mechanisms encoded in the genome to overcome the anti-viral responses in both the 
arthropod and primate hosts. In general, to emerge and persist in an interspecies 
transmission and become a successful arbovirus, a virus must achieve two feats. The 
first feat is replication in vertebrate host cells, which also involves several adaptation 
steps: entering and replicating in an appropriate cell type, overcoming any immediate 
host defense mechanism, exiting from the cell, producing a viremia high enough to be 
transmitted through an arthropod vector to another vertebrate host. The second feat is 
adaptation for replication in arthropod cells for long enough to reach the next 
arthropod-vertebrate encounter without provoking any impairment in arthropod 
mobility and/or feeding. During this period, the virus should be able to enter and 
replicate in arthropod cells, subverting the arthropod anti-viral mechanisms and at the 
same time, keeping the ability to later infect vertebrate cells (Adapted from Webby R. 
et al. 2004). The following paragraphs will be committed to illustrate the ecology of 
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dengue viruses and the different molecular constraints that they have surpassed to 
settle and maintain their interspecies transmission. 
2.1.5. Ecology of DENV and molecular constraints for their evolution 
Dengue viruses are maintained in two ecologically and evolutionarily distinct 
transmission cycles: the urban (or epidemic) and sylvatic cycles (Fig. 10). The natural 
vertebrate host in the sylvatic cycle is non-human primate and the literature reports 
two documented foci of sylvatic transmission in Senegal and peninsular Malaysia 
(Diallo M et al. 2003, Rudnick A. 1986).  In these two foci the principal vectors are 
arboreal mosquitoes. In the epidemic cycle, however, DENV is efficiently sustained 
through human-mosquito-human infection cycles, without the need for the natural 
vertebrate non-human primate host. In the epidemic cycle, DENV is transmitted by 




Adapted from Vasilakis N et al. (2011) 
Figure 10. Transmission cycles of dengue virus. The zone of emergence is where 
sylvatic cycles contact susceptible human populations in rural areas of SE Asia and 
West Africa. Furthermore, it is suggested that dengue virus can persist in mosquito 
populations by transovarian transmission (TOT), in which virus is transferred from 
infected mosquitoes to their eggs. 
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Although transovarian transmission has been reported to serve as a mechanism of 
DENV maintenance in endemic areas during long dry seasons or interepidemic 
periods, blood feeding on infected humans remains the main route of mosquito 
infection (Khin MM & Than KA. 1983, Gunther J et al. 2007). The midgut mosquito 
epithelium is the first place that DENV infect and replicate in; then they spread 
through the hemolymph to others organs and infect the salivary gland 10–14 days 
after the blood meal (Salazar MI et al. 2007), this time is also known as extrinsic 
incubation period (EIP). Thus DENV must overcome certain molecular constraints in 
this journey from the bloodmeal to the salivary glands. 
Apart from the required presence of DENV in the blood meal and their survival to the 
digestive environment of the midgut, to ensure infection DENV must also bind to 
surface molecules on the epithelium to induce clathrin-mediated endocytosis and enter 
the cells (Acosta EG et al. 2008). This process is executed by interaction between the 
viral envelope glycoprotein and several membrane receptor proteins on mosquito cells 
(Reviewed by Smith DR. 2012). These receptors may have a broad but limited 
affinity to E proteins, exerting a positive selection on the DENV quasispecies. Since 
only those viral particles that can recognize and attach avidly to those receptors will 
successfully enter the midgut epithelial cells, and hence founding the first molecular 
constraint for DENV transmission and envelope protein evolution (Lin SR et al. 
2004). Additionally, the E proteins should be competent to later mediate viral entry in 
human cells that have distinct membrane receptors with distinct affinities (Reviewed 
by Hidari KI & Suzuki T. 2011) narrowing the range of E protein genetic diversity. 
However, recent reports suggest that DENV structure differs in the two hosts (Fig. 2); 
displaying a highly ordered structure at 28°C in the mosquito and a less ordered 
organization above 34°C, as in human cells (Zhang X et al. 2013, Fibriansah G et al. 
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2013), indicating that envelope proteins may express distinct binding sites in the two 
hosts and thus overcoming this molecular constraint.  
Once in the midgut cells, DENV has to replicate and spread within the vector, but it 
has been shown that the mosquito midgut serves as a selective filter for DENV, in 
which genetically different escape mutants are selected from the viral quasispecies 
present in the blood meal to be spread in the mosquito, infect the salivary gland and 
transmit to humans (Lin SR et al. 2004, Khoo CC et al. 2013). In the midgut and in 
the salivary glands, mosquitoes are able to mount a potent innate immune response 
using RNA interference (RNAi) and the Toll and JAK-STAT pathways (Xi Z et al. 
2008, Souza-Neto JA et al. 2009). Therefore, exclusively those virus variants that 
subvert this immune response, especially by RNAi, are positively selected since 
experimental impairment of the RNAi pathway has been shown to increase virus 
replication, reduce the extrinsic incubation time and thus increase transmission 
efficacy (Sánchez-Vargas I. 2009). In addition, RNAi appears to provide specific 
resistance to DENV replication in Aedes mosquitoes with some Dicer-2 genotypes 
(Lambrechts L et al. 2013).  
As a result of the selective pressure exerted by RNAi on DENV populations, DENV 
have evolved several mechanisms to circumvent the RNAi response: sequestrating the 
virus replication complex (RC) in double membrane vesicles (DMV) (Ko KK et al. 
1979), producing NS proteins that interfere with the recognition of viral RNA by the 
RNAi pathway (Kakumani PK et al. 2013), avoiding cellular miRNAs, evolving 
highly structured 3’UTRs to avoid inhibition by host microRNAs (Cullen BR. 2013) 
and generating defective interfering viral particles that might also play a role in the 
circumvention of the RNAi response, thus establishing a persistent infection in 
mosquito cells (Juárez-Martínez AB. 2013). Moreover, DENV might use the RNAi 
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machinery to modify the microRNA profile in the cell and modulate the expression of 
host factors co-opted for DENV replication (Hess AM. 2011, Cambell CL et al. 2013) 
and produce the required viral load to be injected with the saliva in the vertebrate 
host. 
Once in the vertebrate host, the anti-inflammatory, anti-haemostatic and 
immunomodulatory factors in mosquito saliva are able to impair the host antiviral 
immune response, increasing the likelihood of pathogen transmission and resulting in 
increased viral infectiveness (Reviewed by Schneider BS & Higgs S. 2008). In the 
human skin, the first cells encountered and infected by DENV are Langerhans’ 
dendritic cells, where the first round of replication is suggested to take place (Wu SJ 
et al. 2000, Cerny D et al. 2014, Schmid MA et al. 2014). DC infection proceeds by 
initial binding to surface molecules and cell membrane receptors, inducing viral entry 
by receptor-mediated endocytosis, in which, after fusion with a lysosome, the pH 
modification induces conformational changes in the envelope proteins, leading to the 
fusion of the viral envelope with the endosomal membrane and the subsequent release 
of the viral RNA into the cytoplasm for replication (Kuhn RJ et al. 2002, Smith JM et 
al. 2011). 
In a dengue naïve individual, where the infectiousness of the virus depends entirely on 
the intrinsic capacity of the viral particles to enter the cells, only those virions whose 
envelope glycoproteins have the conserved motifs and a fully functional structure, 
will infect these DCs. During viral replication, innate immune mechanisms, which are 
essential for host defense against DENV, are activated as a result of the binding of 
pattern recognition receptors (PRRs) to pathogen associated molecular patterns 
(PAMPs) present in the DENV structure (Chang TH et al. 2006, Nasirudeen AM et 
al. 2011, Chen HW et al. 2013), resulting in interferon α/β (type I IFNs) and TNFα 
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production, cell activation and migration to the lymph nodes (Johnston LJ, et al. 
2000). However, activation and cytokine production in the early stages of infection 
may be impaired by the effect of immunomodulatory molecules in the mosquito saliva 
(Reviewed by Schneider BS & Higgs S. 2008). Once in the lymph node, DENV infect 
other DCs and monocytes/macrophages for several rounds of virus replication, 
producing DENV quasispecies. During this time, DENV faces the innate immune 
response as well as the development of an early-acquired immune response that 
collectively tries to control the infection and prevent dissemination (Reviewed by Sun 
P & Kochel TJ. 2013). Hence DENV strains that are able to overcome the early 
immune responses will disseminate through the bloodstream and infect other cells in 
the body and produce viremia levels high enough to infect blood-feeding mosquitoes. 
These events hence allow for the selection of the fittest strains to circulate in the 
human-mosquito-human cycle.  
To confront the innate immune response, DENV have successfully evolved immune 
escape and subversion mechanisms. First, it is able to hide from innate immune 
sensors by sequestering the RC in DMVs whose formation is facilitated by the 
induction of autophagy (Heaton NS & Randall G. 2010). Furthermore, the NS3 
protein is able recruit fatty acid synthase to synthesize fatty acid de novo that are then 
integrated into the DMVs (Heaton NS et al. 2010). DENV genome also encodes 
several factors that enable it to inhibit or evade type I IFN response. The NS2B-NS3 
protease complex has been shown to antagonize type I IFN production through its 
proteolytic activity (Rodriguez-Madoz JR et al. 2010, Aguirre S et al. 2012). Other 
DENV NS proteins, including NS2A, NS4A, NS4B and NS5 are also able to co-opt 
host proteins to distinct elements of the IFN signaling pathway, such as STATs. 
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Importantly, the binding and degradation of STAT2 by NS5 plays a critical role in the 
restricted host tropism of DENV to primates (Morrison J et al. 2012 & 2013).  
Overall, the biology of DENV biology, mainly high substitution rate, allows the 
emergence of a viral population and defective interfering virion that may have critical 
functions in DENV replication, transmission and subversion of innate immune 
mechanisms in mosquitoes and humans, thus driving DENV evolution. (Li D et al. 
2011, Kurosu T. 2011). 
2.1.6. Molecular evolution of dengue virus 
The World War II had a dramatic impact in DENV evolution and Epidemiology. The 
intensive movement of human population and the spread of Aedes aegypti all over the 
world set the conditions for the rapid hyperendemicity of the 4 DENV serotypes 
observed in the post-war time. Moreover, the uncontrolled urbanization and explosive 
human population growth has further fueled the rapid expansion of DENV endemic 
areas. This expansion has not only been consistent with an increased DENV diversity 
but also with subsequent clade replacements and lineage extinctions (Goncalvez AP et 
al. 2002, Wittke V et al. 2002, Zhang C et al. 2005). 
The emergence of RNA sequencing technologies and the advances in bioinformatics 
tools have allowed us to characterize DENV strains, obtain more precise and robust 
phylogenies and understand how intrinsic factors such as population dynamics, 
evolutionary rates and selection pressures influence DENV evolution. These 
technologies improved out understanding of evolutionary relationship across and 
within DENV serotypes and to introduce the term ‘genotype’ (Rico-Hesse R. 1990), 
defined as a cluster of DENV strains whose nucleotide sequence did not differ more 
than 6% within a given genome region. Thus, several genotypes have been found 
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within each serotype, and their radiation, lineage extinctions and clade replacements 
have been described. 
DENV-1 
Phylogenetic studies based on E gene (Fig. 11) o the complete ORF sequences from 
DENV-1 have recognized several lineages that are grouped in 5 genotypes:  
(I) Genotype I represents strains from Southeast Asia, the Middle East (Saudi Arabia) 
and China. Within this genotype, several clades were related to outbreaks that shared 
specific spatiotemporal links. 
 
 
Figure 11. Phylogeny of Dengue Virus Type 1. Maximum Likelihood tree of DENV-
1 strains based on complete E gene nucleotide sequences. Adapted from Chen R & 





 (II) Genotype II, including two strains collected in Thailand in the 1950s and 60s. 
These strains have never been isolated again, suggesting that either they circulate a 
low frequency or silently and have escaped surveillance or they have become extinct. 
(III) Genotype III includes the only two sylvatic isolates so far collected in Malaysia. 
However, their sylvatic nature still remains to be proven since their phylogenies based 
on E gene (Wang E et al. 2000) and ORF sequences differed (Vasilakis N & Weaver 
SC. 2008). The latter study did not place these Malaysian canopy isolates in a basal 
position within DENV-1 serotype. It has been suggested that these isolates may 
represent spillback events from humans into to non-human primates rather than actual 
sylvatic isolates. Interestingly, a human DENV-1 isolation in 2005 clustered with 
these isolates, further supporting the spillback hypothesis. Genotype IV represents 
strains from the Western Pacific islands, Asian countries on the Pacific and Australia 
(A-Nuegoonpipat A et al. 2004). Remarkably, DENV-1 isolates from diverse places 
in the Caribbean (1977–85) and the island of La Reunion in the Indian ocean (2003–
6) are also grouped within this genotype, highlighting the role of global trade and 
frequent human movement on DENV spread. Lastly, genotype V includes most 
DENV-1 strains collected in the Americas, and some isolates from Asia and West 
Africa. In general, all DENV-1 genotypes shared a topology with a basal location of 
oldest strains and a pattern of evolution radiating in spatially defined clades. 
 DENV-2 
Although early studies identified 4 major genotypes in DENV-2 strains (Rico-Hesse 
R 1990), subsequent analysis revealed the existence of two additional genotypes with 
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restricted geographic distribution (Twiddy SS et al. 2002). Currently, DENV-2 strains 
are grouped within six genotypes (Fig. 12):  
(I) Asian genotype I represents strains from Malaysia, Thailand, Myanmar, 
Cambodia, Vietnam and Australia. This genotype also includes the reference strain 
16681, isolated in 1964 from a Thai patient with severe dengue. Of interest, the 
introduction of the Asian genotype I into Vietnam from Thailand in the 90s displaced 
the SE Asian/American genotype and became the dominant lineage in the region (Vu 
TT et al. 2010).  
 
 
Figure 12. Phylogeny of Dengue Virus Type 2. Maximum Likelihood tree of 
DENV-2 strains based on complete E gene nucleotide sequences. Adapted from 




(II) Asian genotype II includes strains from China, the Philippines, Indonesia, 
Taiwan, India, Sri Lanka, Mexico and Honduras. This genotype also includes the 
prototype strain New Guinea C (NGC) isolated in 1944 (Sabin AB. 1952). Even 
though some strains isolated independently (China, Honduras, Mexico) are 
genetically similar to the NGC prototype strain they have been considered laboratory 
contaminations (Chen R & Vasilakis N. 2011). The sole isolate from Taiwan is an 
imported case from the 1998 outbreak in The Philippines (Huang JH et al. 2007).  
(III) The topology of the Southeast (SE) Asian/American genotype suggests a 
geographical division into two clades: all isolates from Southeast Asia and strains 
collected in Americas over the last 30 years. Originally, it was thought that the 
founder of this clade was introduced into Cuba from Vietnam in 1981 (Kouri GP et al. 
1989). However, a recent publication showed that the 1981 outbreak was caused by a 
strain genetically related to NGC strain (Rodriguez-Roche R et al. 2014), leaving 
Jamaica 1985 strain as the founder of this genotype in the Americas. Regardless of the 
source and date, the introduction of this genotype in the Americas had profound 
public health consequences. For the first time in the Western hemisphere, dengue 
virus infection was associated with severe disease and during the next 30 years, 
strains from this genotype have been responsible for major epidemics with increased 
pathogenicity throughout the Americas (Rico-Hesse R et al. 1997) and displaced less 
virulent strains of the American genotype from this continent (Watts DM et al. 1999).  
(IV) Cosmopolitan genotype represents strains distributed in two clades; one 
includes isolates from East and West Africa, the Middle East, the Indian subcontinent, 
Australia, Indian and Pacific Ocean Islands. Singularly, all Indian isolates in this 
genotype were collected after 1971, when this genotype entered the Indian 
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subcontinent and replaced the American genotype as the dominant genotype (Kumar 
SR et al. 2010). This clade also includes a set of strains from Uganda, Australia, Fiji, 
Singapore, and Malaysia. The latter isolates are found deeply basal in the genotype, 
indicating that these countries may represent the origin of this clade. Likewise, in the 
cosmopolitan genotype, another clade appears to circulate widely and dominate in the 
Pacific Rim, causing outbreaks in Taiwan, Singapore, Malaysia and the Philippines 
(Chen R & Vasilakis N. 2011).  
(V) American genotype, representing older strains collected in the Pacific Islands 
and the Indian subcontinent and more recent strains from the Caribbean, Central and 
South America. This genotype was later replaced by the Cosmopolitan genotype in 
the India subcontinent (Kumar SR et al. 2010) and by the SE Asian/American 
genotype in the Americas. Historically, this genotype was associated with mild 
dengue infection and is thus considered a genotype of low epidemiological impact 
(Rico-Hesse R et al. 1997). However, some outbreaks of this genotype in the 1970s in 
Puerto Rico, Tahiti, New Caledonia and Niue included severe dengue cases (Steel A 
et al. 2010, Lopez-Correa RH et al. 1978). 
Lastly, (VI) the sylvatic genotype includes strains from canopy-dwelling arboreal 
mosquitoes, humans and non-human primates collected in SE Asia and West Africa 
(Weaver SC & Vasilakis N. 2009). Interestingly, a recent study demonstrated that 
sylvatic DENV and human DENV evolve similarly, showing that the pattern of 
selection, mutation and replication in DENV2 are largely equivalent across its host 






DENV-3 phylogenetic studies based on the E gene (Fig. 13) or complete genome 
sequences have identified four distinct DENV-3 lineages (Lanciotti RS et al. 1994, 
King CC et al. 2008, Araujo JM et al. 2009A). However, more recent research 




Figure 13. Phylogeny of Dengue Virus Type 3. Maximum Likelihood tree of 
DENV-3 strains based on complete E gene nucleotide sequences. Adapted from 




(I) Genotype I, representing strains from Southeast Asia, mainly the Malaysian 
peninsula, Singapore, Indonesia, the Philippines, Taiwan, and the South Pacific 
Islands (Fiji and Tahiti). In general, this genotype includes most Indonesian isolates 
from 1973–83 and 1998–2009 and appears to have been evolving independently in 
this country over the past 30 years and radiating westward in the region (Araujo JM et 
al. 2009A).  
(II) Genotype II is represented mostly by strains from Thailand since 1962 until 
recent epidemics, a single Singaporean strain in 1995, one Indonesian strain isolated 
in 1998 and strains sampled from Vietnam, Taiwan, Bangladesh, Cambodia, 
Myanmar, China and Japan. The genotype II DENV-3 seems to have been evolving 
independently in Thailand over the past 50 years, and radiating to countries in the 
continental SE Asia with occasional importations into China, Taiwan and Bangladesh 
(Araujo JM et al. 2009A, Ito M et al. 2007).  
(III) Genotype III, as the most widely spread DENV-3 lineage, includes isolates from 
India, Sri Lanka, Japan, Taiwan, Samoa, Singapore, East Africa, Central and South 
America, the Caribbean and two imported cases in Europe. This genotype appears to 
have emerged in the Indian subcontinent and spread westward into Africa in the 
1980s and later into the Americas (Gubler DJ et al. 1986). The introduction of this 
genotype into the Americas in the 1990s coincided with explosive epidemics 
associated with an increased incidence of severe dengue (Araujo JM et al. 2009A). 
(IV) Genotype IV includes strains collected in Puerto Rico and Tahiti in the 1960s 
and 1970s (Lopez-Correa RH et al. 1978, Laigret J et al. 1967). This genotype has 
only been associated with mild dengue (Neff JM et al. 1967) and is the most 
genetically distinct from other DENV-3 lineages. Additionally, the silent transmission 
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of these strains has been suggested to occur in Tahiti as well as in Puerto Rico in 
inter-epidemic periods.  
Lastly, (V) genotype V, representing the prototype H87–1956 DENV-3 strain from 
the Philippines (Hammon WM et al. 1960), includes an 1973 Japan isolate, strains 
from China (1987 and 2009) and Brazil (2002-2004) Considering the high nucleotide 
substitution rate that characterize DENV (Twiddy SS et al. 2003), it is highly likely 
that these samples – which are similar to the prototype strain H87 (isolated nearly 50 
years ago) – represent laboratory contaminations (Chen R & Vasilakis N. 2011).  
Although no sylvatic DENV-3 isolation has been reported to date, it is believed that 
sylvatic strains circulate in SE Asia based on the seroconversion of sentinel non-
human primates (Rudnick A & Lim TW. 1986). Overall, The evolution of DENV-3 is 
characterized by spatially contained viral population and limited co-circulation of 
distinct genotypes. 
 DENV-4 
Although early research identified only 2 genotypes of DENV-4 (Lanciotti RS et al. 
1997), more recent work delineated 4 major genotypes (Fig. 14) (Weaver SC & 
Vasilakis N. 2009).  
(I) Genotype I represent strains from The Philippines, Malaysia, Vietnam, Thailand, 
Myanmar, Sri Lanka, India and some imported cases in Japan, China and Brazil 
(Weaver SC & Vasilakis N. 2009). This genotype also includes the prototype DENV-
4 isolate (H241) from the Philippines in 1956 (Hammon WM et al. 1960).  
(II) Genotype II includes strains from Indonesia, Singapore, Malaysia, China, 
Australia, Western Pacific islands, the Caribbean and the Americas. In this genotype, 
there is a spatiotemporal division into two clades: clade I represents all strains from 
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the Americas and most Asian strains sampled before 2000 (Indonesia, Singapore, 
Malaysia, New Caledonia and Tahiti). The introduction of this genotype from SE Asia 
into the Americas appears to have occurred in the 1980s through the Caribbean or 
South America (Foster JE et al. 2003, Carrington CV et al. 2005). Clade II is 
represented by all Asian isolates collected after 2000.  
 
 
(III) Genotype III, represented by five recent strains isolated in Thailand between 
1997 and 2001. They appear to differ from all other Thai isolates (Klungthong C et al. 
2004).  
Figure 14. Phylogeny of Dengue Virus Type 4. Maximum Likelihood tree of 
DENV-4 strains based on complete E gene nucleotide sequences. Adapted from 




Lastly, (IV) genotype IV, representing three sylvatic DENV-4 strains isolated from 
sentinel monkeys during the 1970’s in Malaysia. All sylvatic DENV-4 strains are 
genetically distinct and basal to the clades I-III, supporting the notion that they 
represent an ancestral genotype (Wang E et al. 2000). 
Overall, all DENV-4 genotypes are characterized by a basal location of the oldest 
strains, confirming the radiating pattern of evolution found in other serotypes, but in 
this case around temporal rather than spatial clades (Foster JE et al. 2003). 
Remarkably, the two major genotypes –genotypes I and II – have not experienced 
direct competition between them; genotype I has remained circulating mainly in 
continental SE Asia while genotype II has been evolving independently in SE Asia 
and the Americas for the past 30 years (Villabona-Arenas CJ & Zanotto PM. 2011). 
 2.1.7. Viral and epidemiological fitness 
Viral fitness was primarily defined as the relative ability of a virus to survive and 
produce infectious progeny in the environment where it finds itself (Domingo E & 
Holland JJ. 1997). Currently, this definition remains widely used and accepted and 
frequently it alludes more precisely to replicative fitness – which can be measured in 
vitro (cell cultures and tissue explants) or in vivo (within individual hosts). However, 
this definition does not exactly match the Darwinian definition of fitness, which is the 
average genetic contribution to the next generation made by an individual of a given 
genotype (Orr HA. 2009). For viruses, it is not fully accomplished mainly due to their 
host-dependent replication and their limited within-host viral lifespan, which in turn 
depends on the immune viral clearance in the host and the host finite lifespan. 
Therefore, viruses must be transmitted to a new host to survive, underlining 
transmission fitness as a crucial component of viral fitness. Thus, replication and 
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transmission both contribute to the over-time survival of a given viral genetic material 
at a population level in the field (Wargo AR & Kurath G. 2012).  
Moreover, a virus strain (serotype, genotype or clade) may have the capacity to 
become dominant with respect to other viruses of the same species in the field; this 
capacity defines the epidemiological fitness of the virus (Domingo E. 2010). Hence, 
examining over time the changes in prevalence, distribution and composition of viral 
genotypes in the field we may define their relative fitness. The understanding of 
DENV replicative, transmission and epidemiological fitness can shed new insights on 
the mechanisms that govern viral evolution, emergence and displacement in the field 
(Figure 15 summarizes the different systems currently used to study viral fitness). 
(Wargo AR & Kurath G. 2012). 
 
 
As a human pathogen, DENV fitness and its role in viral emergence and evolution 
have been of great interest. A growing body of evidence suggests that the assessment 
of replicative and transmission fitness in the laboratory correlates with the 
displacement and prevalence of dominant DENV strains in nature (Armstrong PM & 
Rico Hesse R. 2003, Cologna R & Rico-Hesse R. 2003, Anderson JR & Rico-Hesse 
Figure 15. Research systems used to investigate replicative, transmission and 
epidemiological fitness.  
Adapted from Wargo AR & Kurath G. (2012) 
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R. 2006, OhAinle M et al. 2011, Lambrechts L et al. 2012, Chourdhury MA et al. 
2014, Quiner CA et al. 2014). 
The displacement of the circulating serotype as consequence of the introduction of 
another serotype has been broadly described (Thu HM et al. 2004, Li DS et al. 2010, 
Yamanaka A et al. 2011, Dask PK et al. 2011, Reviewed by Messina JP et al. 2014). 
It has been suggested that the main driving force for this phenomenon is the low 
serotype-specific immunity in the population and the concomitant amplifying effect of 
ADE of DENV infection. This hypothesis has been further supported by a dynamic 
system model (Cummings DA et al. 2005), which proposes that those serotypes 
undergoing antibody-dependent enhancement may have a competitive advantage over 
those serotypes that do not.  However, a complex interaction between population 
dynamics of serotype-specific immunity and viral genetics appears to provide major 
contribution to viral evolution and determine epidemiological fitness and virulence 
(OhAinle M et al. 2011).  
In this regard, several serotype displacements and epidemics have correlated with a 
change in the circulating genotype, indicating that viral genetics also plays a role in 
virulence and epidemiological fitness (Zhang C et al. 2005). As an example, the 
emergence and global spread of the DENV-3 genotype III triggered a series of 
serotype displacements in the Americas as well as in the Indian subcontinent and SE 
Asia, despite DENV-3 was already endemic in the two latter regions (Masser WB et 
al. 2003). Hence, this genotype was able to dominate and replace other DENV-3 
genotypes in these regions, along with the emergence of DHF in Sri Lanka for the 
first time in 1989 (Messer WB et al. 2002). A subsequent study reported that the 
dominant DENV-3 strain infects and spreads in Aedes aegypti with greater efficiency 
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than the native DENV-3 strain, confirming a better epidemiological and transmission 
fitness in the DENV-3 genotype III (Hanley KA et al. 2008). 
On the other hand, the study of the DENV molecular evolution has also revealed 
several genotype replacements that may describe and add more evidence on the 
impact of viral genetics on epidemiological fitness (Chen R & Vasilakis N. 2011). For 
instance, the introduction of the SE Asian/American DENV-2 genotype in the 
Americas represented a major epidemiological event that not only had important 
public health consequences (Rico-Hesse R et al. 1997) but also revealed the 
epidemiological fitness and hence dominance of the SE Asian/American genotype 
over the endemic American DENV-2 genotype. Hence, the latter genotype was fully 
displaced and is currently considered extinct from the American continent or at least it 
has escape detection for the last 20 years. Remarkably, it was shown that SE 
Asian/American strains are more efficient at infecting and disseminating in Aedes 
aegypti and thus increasing its vectorial capacity (Armstrong PM & Rico Hesse R. 
2003, Anderson JR & Rico-Hesse R. 2006). A further study also suggests that 
structures in American genotype significantly decrease DENV output from DCs and 
human monocytes (Cologna R & Rico-Hesse R. 2003), explaining its low virulence 
and perhaps its lower viral fitness with respect to SE Asian/American genotype in the 
Americans and the Cosmopolitan genotype in the Indian subcontinent. Likewise, the 
SE Asian/American DENV-2 genotype was replaced from SE Asia by a dominant 
clade of the Asian I genotype, this replacement was attributed to the ability of this 
genotype to reach higher viremia in humans, and thus to increase the rate of human-
to-mosquito transmission (Vu TT et al. 2010). 
Other pieces of evidence have supported the correlation between transmission and 
epidemiological fitness at a clade level, such as the major DENV-1 clade replacement 
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that occurred within genotype I strains circulating in Thailand during the 1990s. This 
clade replacement was associated with an enhanced mosquito transmission in the 
dominant clade (Lambrechts L et al. 2012). Similarly, Quiner CA et al. (2014) 
reported an increased replicative fitness in native mosquitoes for a DENV-2 dominant 
lineage in Nicaragua compared to other strains of the same genotype. Nonetheless, the 
two studies also showed a substantial variation in replicative and transmission fitness 
among the isolates from the same clade, suggesting that evolutionary forces, other 





Year Serotype/Genotype Context 
Clade 
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Puerto Rico 1994 DENV-2 
SE Asian/American 
Outbreak 
 Nicaragua 2005 DENV-2 
SE Asian/American 
Outbreak 
 Singapore 2005 DENV-2 
Cosmopolitan 
Outbreak 
 Thailand 1990s DENV-1 Outbreaks 
 Brazil 1990s DENV-1 
Genotype I 
Outbreaks 
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The phenomenon of lineage replacement has been recognized as a common feature 
across consecutive epidemic outbreaks caused by the SE Asian/American DENV-2 
genotype in the Americas (Mir D et al. 2014). These findings indicate that minor 
changes in viral genetics may lead to epidemiological events more frequently than 
expected. In addition, a growing number of clade replacements within the same 
genotype have been associated with epidemiological consequences in the Pacific 
Islands, Indonesia, Singapore, Malaysia, India, Brazil, Puerto Rico and Mexico 
(Table 1) (Dupont-Rouzeyrol M et al. 2014, Kokati T et al. 2014, Lee KS et al. 2012, 
Teoh BT et al. 2013, Manakkadan A et al. 2013, Carneiro AR et al. 2013, McElroy 
KL et al. 2011 and Carrillo-Valenzo E et al. 2010, respectively). Unfortunately, more 
data on the replicative and transmission fitness of these strains are still required to 
better understand the evolutionary forces behind the change of circulating strains.  
The developments in bioinformatics have provided new tools to study DENV lineage 
shifts and some attempts succeeded at finding positive selection in the genome of 
dominant strains (Benett SN et al. 2006, Bedi SK et al. 2013, Dash PK et al. 2015), 
whereas other studies did not (Teoh BT et al. 2013), suggesting that clade 
replacements can also represent stochastic events independent from positive selection. 
However, most of such studies rarely investigated natural selection at complete 
genome level. Strikingly, the few well-characterized lineage replacements appeared to 
involve several amino acid substitutions in the coding region, most of them in the 
non-structural proteins and some nucleotide substitutions and indels in the UTRs, 
hindering the establishment of a direct molecular correlation between viral genetics 
and epidemiological fitness. For instance, the 2005-2007 Nicaragua DENV-2 clade 
replacement involved two amino acid substitutions in structural proteins, nine in NS 
proteins, three nucleotide substitutions and one insertion in the UTRs (OhAinle M et 
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al. 2011). Likewise, the 1994 Puerto Rico outbreak was characterized by the 
introduction of a foreign clade of DENV-2 SE Asian/American genotype and the 
replacement of the endemic clade, despite this lineage was endemic in the island for at 
least ten years. McElroy KL et al. (2011) reported that one amino acid substitution in 
the Envelope protein and 11 amino acid substitutions in NS structural proteins could 
have been involved in this clade replacement. A previous work also identified positive 
selection in one amino acid in the Envelope protein, but this study was limited to the 
structural proteins, disdaining the impact of the amino acid substitutions in NS 
proteins and the nucleotide substitutions in UTR in viral and epidemiological fitness 
(Benett SN et al. 2006).    
To gain insights into how DENV viral genetics could shape the epidemic potential of 
DENV strains, we isolated and sequenced DENV-2 strains from human serum 
samples collected during the 1994-1995 Puerto Rico outbreak (Manokaran G. 2014). 
Using complete coding sequences of these isolates and other published DENV-2 
sequences from Puerto Rico and neighboring countries, we constructed a Maximum 
likelihood phylogenetic tree (Fig. 16) that showed the three major lineages from the 
SE Asian/American genotype that have circulated in Puerto Rico since 1986, as 
previously reported (McElroy KL et al. 2011). Firstly, an endemic lineage that 
circulated in the island since the introduction of this genotype in the Americas in 1986 
up to 1995. Secondly, a foreign lineage that represents most strains collected in Puerto 
Rico from 1994 to 2007 and in a basal position some isolates from neighboring 
countries collected in 1990–1998, confirming the foreign character of the lineage and 
suggesting that it was introduced in Puerto Rico from one of these countries in 1994. 
Moreover, this lineage became dominant and persisted as the dominant DENV-2 
lineage in the island at least up to 2007. Lastly, a third lineage representing strains 
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sampled in Puerto Rico and several Caribbean countries between 1987 and 2006, 




As the phylogenetic tree also shows (Black dots), most of our clinical samples are in a 
basal position in the foreign dominant (FD) lineage and in a distal position in the 
Figure 16. Phylogeny of DENV-2 strains from Puerto Rico and Caribbean 
countries. Maximum likelihood tree based on 158 complete ORF nucleotide 
sequences from DENV-2 strains isolated in Puerto Rico and neighboring countries 
between 1985 and 2007. The statistical support for the topology was determined by 




endemic lineage, indicating that these isolates perfectly represent the two main 
competing lineages during the 1994 Puerto Rico outbreak, when the FD lineage 
overtook the endemic lineage. 
Amino acid substitutions  Endemic   Foreign 
Dominant 
Gene  Position  aa (%)  aa (%)  
E  91  V (100)  I (100)  
 491  A (100)  V (100)  
NS1  10  S (100)  N (100)  
 164  T (68)  S (92.3)  
NS2A  72  I (76)  V (100)  
NS2B  8  I (92)  V (100)  
NS3  31  L (100)  F (84.6)  
 418  R (100)  K (92.3)  
NS4A  36  A (100)  V (76.9)  
NS4B  19  A (80)  I (76.9)  
 175  I (100)  V (76.9)  
NS5  269  S (100)  N (92.3)  
 375  K (100)  R (100)  
 435  I (100) V (100)  
 514  R (100)   K (92.3)  
 596  R (100)  K (100)  
 891  R (100)  K (92.3)  
Nucleotide substitutions  Endemic Foreign 
Dominant 
UTR  Position  nt (%)   nt (%)  
5’ 40  U (100) G (100) 
 48  A (100) U (100) 
3’  10301  A (100) G (100) 
 10331  G (100) A (100) 
 10389  U (76) C (92.3) 
 
 
Table 2. Amino acid and nucleotide substitutions present in the different 
genomic segments of the 1994 Puerto Rico DENV-2 strains. Position, residue and 
percentage of isolates in each lineage bearing the substitution are shown. 
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The sequencing of these isolates also revealed the presence of 17 amino acid 
substitutions in the coding region – two in Envelope protein and 15 in NS proteins, 
two nucleotides substitutions in the 5’ UTR and three more in the 3’ UTRs (Table 2). 
In order to identify which substitutions better explain the splitting of the complete 
genome tree into two main lineages, we aligned the Puerto Rico isolates’ sequences 
by gene and applied the Shimodaira-Hasegawa Test, which compares the topology of 
the each gene to the topology of the complete genome tree. This analysis suggested 
that NS1, NS3, NS5 and 3’UTR phylogenetic trees better correlate with complete 
genome tree, indicating the substitutions in these genes may have conferred greater 
epidemiological fitness to the dominant lineage and explain the segregation of the 
strains in two lineages. 
Notably, the three substitutions in the 3’ UTR mapped to the variable region, where 
conserved structures were found to be required for sfRNA production (Chapman EG 
et al. 2014A). Therefore, we wondered whether these substitutions would have an 
impact on sfRNA production and whether differential sfRNA production could confer 




Although the replicative fitness (Fig. 17) – as tested in cultured cells – suggested that 
endemic strains produce a greater genomic RNA progeny than the FD lineage at 24 
Figure 17. Replicative fitness of 1994 Puerto Rico DENV-2 strains. Huh-7 Cells 
were infected with Endemic and FD DENV-2 strains at a Multiplictiy of Infection 
(MOI) of 0.1 and (A) Plaque titers, (B) gRNA, (C) sfRNA and (D) sfRNA:gRNA 
Ratio were quantified at 24 hpi. 
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hours post infection, the sfRNA production was found to be comparable between the 
two lineages. Further experiments showed that the FD strains recover their genomic 
RNA production and overtake the endemic strains at 72 hours p.i. Overall; the FD 
strains appeared to produce a higher sfRNA/genomic RNA (gRNA) ratio. 
Furthermore, we found that the sfRNA from the two DENV-2 lineages inhibit the 
IFN- expression at equivalent concentrations (Fig 18). Thus, the greater sfRNA 
production in the FD strain may reduce IFN- expression in infected cells, allow the 




To identify the mechanism behind the inhibition of IFN- expression, we searched for 
the proteins that bind to the sfRNA and may mediate the inhibition of IFN-β 
expression. We used a RNA chromatography and quantitative mass spectrometry 
approach described by Ward A et al. (2014). 1199 proteins were identified in the 
sfRNA and Control RNA pull-downs by quantitative mass spectrometry, 198 of them 
Figure 18. sfRNA inhibit Interferon-β expression. Huh-7 Cells were co- 
transfected with DENV-2 in vitro transcribed sfRNA, Control RNA and Poly IC – a 
TLR3 ligand. IFN-β expression was quantified by qPCR at 24 hp transfection. 
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were found to bind 1.5 fold more frequently to DENV-2 sfRNA from both lineages 









Strikingly, tripartite motif containing 25 (TRIM25) and mitochondrial antiviral 
signaling (MAVS) were significantly enriched in the sfRNA pull-downs (Fig. 19). 
Both MAVS and TRIM25 directly regulate Type I IFN expression through the 
modulation of Retinoic acid-inducible gene 1 (RIG-I) signaling –a foreign RNA 
sensing innate immune mechanism (Gack MU et al. 2007 & 2009). Further 
experiments validated TRIM25 as a sfRNA-binding protein and this binding was 
Figure 19. sfRNA bind to TRIM25 and inhibit RIG-I signaling and IFN-β 
expression.  DENV-2 sfRNA from foreign dominant (FD) strains and endemic 
strains and control RNA were exposed to Heavy (H), Medium (M) and Light (L) 
protein lysates respectively. Bound proteins were eluted and identified in the Mass 
spectrometry according to their isotope labels. Volcano plots display proteins 
enriched in the Endemic (A) and FD (B) DENV-2 sfRNA pull-downs as compared 
to control RNA pull-down – termed as M/L and H/L ratios, respectively. Red dots 
represent significantly enriched proteins. The 4 highlighted proteins (TRIM25, 
MAVS, Mitogen-Activated Protein Kinase 1 - MAPK1, Peroxiredoxin 3 - PRDX3) 
are known to be involved in IFN-β signaling. (C) Dot plot represents the average 
H/L and the M/L ratios for 32 proteins selected by the GO term finder to be 
involved in type-I interferon response. Green dots show proteins whose H/L and 
M/L ratios are lower than 1.5 – considered poorly enriched proteins. Purple dots 
show proteins whose H/L and M/L ratios are higher than 1.5 – enriched in presence 
of both sfRNA, and the blue dots show proteins whose H/L ratio is higher than 1.5 
but their M/L ratio is lower than 1.5 – enriched in the Epidemic sfRNA pull-down 
but not in the FD DENV-2 sfRNA. 
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found to interfere with TRIM25 de-ubiquitination by USP15 – a prerequisite for 
TRIM25 stabilization and function (Pauli EK et al. 2014). Thus, TRIM25 is not 
longer able to polyubiquitylate RIG-I, amplify its signal transduction and trigger type 
I IFN expression.    
Hence, the three substitutions at 3’ UTR increased the sfRNA/gRNA ratio and the 
binding of sfRNA to TRIM25, providing a novel mechanism for DENV 
epidemiological fitness (Manokaran G. 2014).  
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CHAPTER 3: METHODS 
3.1 Sequence conservation analysis. 
The complete genome DENV nucleotide sequences were downloaded directly from 
the GeneBank database. The search included the keywords “Dengue virus type X” 
(X=1–4). In total, 1486, 1073, 831 and 154 sequences were downloaded and included 
in the analysis of the 3’ UTR of DENV-1, DENV-2, DENV-3 and DENV-4, 
respectively. All DENV mutants, vaccine candidate strains, serially passage strains, 
replicons and duplicated sequences were previously excluded.  
To determine the nucleotide composition, the number of identical sites and pairwise 
percent identity (depicted as Average identity) in the 3’ UTR of DENV, multiple 
nucleotide sequence alignments were built for each serotype using MAFTT ((Multiple 
sequence alignment using Fast Furier Transformation) software (Katoh K, Standley 
DM. 2013). This software was preferred over its counterparts because it uses a Fast 
Furrier transformation approach that allows aligning a high number of nucleotide 
sequences (>500) in a considerable short time. The complete genome sequence 
alignments were limited to the 3’UTR, starting from the Stop codon in NS5.  
The Geneious platform was used to calculate nucleotide composition, sequence length 
(mode and range), average identity (i.e. average nucleotide conservation in the 
alignment) and the number of identical sites – 100 percent conserved positions 
(Kearse M et al. 2012). 
To visualize the nucleotide pattern, composition and conservation in the 3’ UTR of 
each serotype, sequence logo were generated using Weblogo server (Crook GE et al. 
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2004). Standard colors were used to represent each type of nucleotide in the alignment 
(Guanine=Yellow, Cytosine=blue, Adenine=Red and Uracil=Green).  
Analysis of Variance (ANOVA) and Bonferroni correction were used to test 
hypothesis from absolute values such as the average identity. Chi-2 test was used to 
test hypotheses from relative frequencies such as nucleotide composition. Regarding 
the substantial differences across the sample size in the four data sets, no comparison 
was performed across serotypes and all statistical methods were performed to test 
hypotheses within each serotype. The statistical analysis was performed using 
STATA software (stataCorp, 2009).  
3.2 Assembly and study of RNA secondary structure. 
To construct the RNA secondary structure and tertiary interactions of DENV 3’UTR, 
I applied a combination of RNA secondary structure prediction software and RNA 
phylogenetics. Even though the RNA phylogeny approach is one of the oldest 
methods to solve RNA structures, it is considered more accurate than any RNA 
secondary structure software based on base-paring probabilities or the minimal free 
energy structure (Jaeger JA et al. 1993). The strength of the RNA phylogeny 
approach relies upon the identification of evolutionary conserved functional RNA 
structures, whose nucleotide sequences evolved, changing the nucleotide composition 
overtime but keeping the RNA secondary and tertiary structures. Hence, it is possible 
to identify conserved RNA structures by finding conserved sequence stretches across 
the species, serotype or genotypes, to predict a preliminary RNA structure by 
applying RNA secondary prediction software and to identify secondary and tertiary 
interaction by identifying co-variations in the non-coding RNA nucleotide sequences. 
Here I combine these two approaches and predict a preliminary RNA structure using 
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base-pairing probabilities on the conserved stretches using RNAfold and HotKnots 
softwares (Lorenz R et al. 2011 and Ren J et al. 2005) and then the RNA secondary 
structure is refined considering the co-variations in the 3’UTR sequence alignment, 
exploiting the high mutation rate of DENV viruses. Figure 21 briefly summarizes the 
approach. 
3.3. Detecting natural selection in the 3’ UTR of DENV  
To determine whether the RNA structures in the 3’ UTR and the sfRNA production 
play a role in the evolution of DENV, selection pressure was examined in a site-by-
site basis in the RNA segment involved in the sfRNA structure using a maximum-
likelihood (ML) method (Wong WS & Nielsen R. 2004). This method models the 
evolution of coding and non-coding regions and assumes a constant neutral 
(synonymous) nucleotide substitution rate in both regions in the same viral genome. 
To model the evolution in the coding region and estimate its synonymous substitution 
rate, I used a model of codon evolution (General Time Reversible, GTR+) that has 
been generally applied to study the ORF of DENV genome (Weaver SC & Vasilakis 
N. 2009). On the other hand, the nucleotide substitution rate in the 3’ UTR was 
calculated in site-by-site basis using a combined model of non-conding RNA 
evolution (Loop model: (Hanley and Knott Regression, HKR+ and Stem model: 
16D) that was adapted to the RNA secondary structure of the 3’ UTR using PHASE 
3.0 software (Allen JE, Whelan S. 2014). Thus, the nucleotide substitution rate in 
each position of the sfRNA sequence was normalized by the synonymous substitution 
rate in the coding region of each DENV serotype. This ratio models a parameter . 
When a nucleotide position in the 3’ UTR exhibits a nucleotide substitution rare 
equivalent to the synonymous substitution rate ( = 1). It indicates a neutral evolution, 
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whereas  > 1 or  < 1 suggest that a given position in the sfRNA sequence has 
undergone the action of positive or negative selection, respectively. Furthermore, the 
95% confidence interval of the  parameter was calculated across each DENV 
genome, thus a  value within the limits confirm the neutral evolution and a  value 
above or below its limits indicate a significant positive and negative selection, 
respectively. 
3.4. Phylogenetics tree of DENV 
To test whether the phylogeny of the sfRNA from DENV-2 clusters DENV-2 strains 
into the six major genotypes described in the literature (Chen R & Vasilakis N. 2011), 
a maximum likelihood phylogenetic tree was constructed from an alignment of 356 
3’UTR DENV-2 sequences from all over the world, using the PHASE 3.0 package 
(Allen JE, Whelan S. 2014). It has been designed precisely to study RNA sequences 
that contain conserved RNA structures. A composed model of nucleotide substitution 
(Loop model: HKR+ and Stem model: 16D) was adapted to the predicted RNA 
secondary structures in the sfRNA from DENV-2. The statistical support for the 
topology of the tree was determined by 1000 bootstrap replications. 
3.5 3D RNA comparative modeling 
A 3D RNA model was built based on the crystallography of the homologous xrRNA 
structure in the Murray Valley encephalitis virus (Protein Data Bank ID: 4PQV), 
using ModeRNA, a software for comparative 3D RNA modeling (Rother M et al. 
2011). A structure-based alignment of the homologous xrRNA sequences of MVEV 
and DENV was built using LocaRNA (Smith C et al. 2010). The sequence alignment 
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and the PBD file served as template for the comparative modeling. The minimization 
MMTK function was used to remove the clashes from the structure. 
3.6 RNA melting prediction 
When the nucleotide substitutions in the dominant DENV strains were co-variations 
of base pairings, I used the UNAFOLD webserver with the default setting to estimate 










CHAPTER 4: RESULTS AND DISCUSSION 
The 3’ untranslated region of the four DENV serotypes displays high sequence 
conservation, similar nucleotide composition and nucleotide distribution pattern 
but differs in sequence length. The variation in sequence length of Domain I 
explains the overall length discrepancy. 
The sequence conservation analysis of the 3’ UTR of each DENV serotype revealed 
that their overall sequence lengths differ across serotypes (Table 3), as Shurtleff AC 
et al. (2001) previously reported. The 3’ UTR of DENV-1 (Mode; Range: 465; 436–
475) was found to be slightly longer than the one of DENV-2 (454; 444–469) and 
DENV-3 (443; 429–455), whereas the 3’ UTR of DENV-4 depicted the shortest 
sequence length among DENV genomes (387; 387–407). The broad range in 
nucleotide length also indicates that this RNA segment is susceptible to major 
deletions and insertions. Several epidemiological reports also confirm a relatively 
frequent emergence DENV strains with deletions in their 3’ UTR (Zhuo Y et al. 2006, 
Pankhong P et al. 2009, de Castro MG et al. 2013). 
Serotype  Sequences 
n 
Length 
Mode [Range]  
Identical sites 
n (%)  
Average identity 
(%)  
DENV-1  1486  465 [436–475]   169 (35.4)  96.5  
DENV-2  1073 454 [444–469] 158 (33.7)  96.0  
DENV-3  831  443 [429–455]  238 (52.3)  97.1  




Table 3. Nucleotide sequence conservation in the 3’ UTR of DENV. This table 
summarizes the conservation analysis of the 3’ UTR of DENV. It includes number of 
sequences included in the study, the mode and range of sequence length, the absolute 
and relative number of identical sites (100% conserved sites) and the average identity. 
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Overall, the 3’ UTR is highly conserved within each serotype (Average Identity: 
>96%). The four serotypes share a common pattern of nucleotide distribution in the 3’ 
UTR, as the sequence logos for each serotype suggest (Fig. 20), indicating the 
presence of conserved structures across serotypes. For instance, some stretches of 
conserved sequences mapped to the start and end of the Dumbbell (DB) structures in 
the Domain II, as described by Shurtleff AC et al. (2001) and Gerhald LG et al 
(2011), allowing the setting of a clear border between the different domains in the 3’ 
UTR of DENV and the study of the nucleotide conservation and composition across 




The sequence conservation analysis of the three domains in 3’ UTR also indicates that 
different sequence lengths in Domain I mainly explain the across-serotypes variation 
in 3’ UTR sequence length (Table 4). Domain I was also found to be significantly 
less conserved than the other domains (p>0.05) (Table 4). Moreover, the comparison 
of the three domains also revealed a significantly higher CG content in Domain II, 
confirming the existence of conserved RNA structures in this segment – the well-
known DB structures.  
 
Figure 20. Sequence logos from the multiple sequence alignment of the 3’ UTR 
of DENV.  The sequence logo for the 3’UTR of each DENV was aligned based on 
the multiple sequence alignment of the consensus sequence logo, revealing the 
location of the nucleotides differences that explain the different lengths in the 3’ 























The Domain I in the 3’ UTR of DENV possesses two distinct regions: a highly 
variable region that may represent a flexible RNA segment and a semi-variable 
region that contains conserved RNA structures. 
The within-serotype sequence logos also revealed a set of conserved stretches in the 
last segment of the variable region (VR or Domain I), suggesting the presence of 
important RNA structures (Fig. 21B). Here, I suggest terming this region as semi-
variable region (SVR) as compared to the 30–50 nucleotides immediately upstream 
that displayed poor nucleotide conservations, and therefore termed as highly variable 
region (HVR). A further sequence conservation analysis, comparing the HVR and 
SVR, corroborated a significantly lower conservation (Average identity: < 89% in all 
serotypes and HVS vs SMV: P>0.001) and significant adenine enrichment in the 
HVR (p<0.05), indicating a lack of conserved RNA structures in this region. Hence, 
this region might represent a flexible region in the genome, as it is susceptible to 
major deletions and substitutions and possesses a high adenine composition. 
Strikingly, the SVR exhibited a high conservation and GC content, further insinuating 
the presence of conserved RNA structures in the SVR of the DENV 3’ UTR. 
Two conserved homologous RNA structures and novel tertiary interactions were 
identified in the semi-variable region of the 3’ UTR. The second homologous 
RNA structure differed across DENV types. Furthermore, the lack of first 
homologous RNA structures explains the shorter 3’ UTR in DENV-4 genome.  
To determine the RNA secondary structures in the SVR, a combination of RNA 
secondary prediction software and RNA phylogenetics was applied (Fig. 21B). A 
consensus alignment for all DENV sequences was built and conserved sequence 
stretches and sequence co-variations were identified. Two groups of five conserved 
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stretches were found to display a repetitive pattern in the SVR, suggesting the 
presence of two homologue RNA structures in this region. A preliminary secondary 
RNA structure was predicted from the sequences in the conserved stretches. RNAfold 
software and Hotknot software were used to estimate the base-pairing probabilities 
and a minimal free energy structure and to identify tertiary interactions, such as 
pseudo-knots (Lorenz R et al. 2011, Ren J et al. 2005). These RNA structures were 
further refined and validated by co-variation of the RNA sequences across DENV 
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serotype, within-serotype and within-genotype. The approach was extended and 
applied to the full length of the 3’ UTR and a consensus RNA secondary structure 
was assembled (Fig. 21A).  
The consensus 3’ UTR secondary RNA structure shows the 3’SL structure in Domain 
III and the DB structures in Domain II, as previously suggested (Shurtleff AC et al. 
2001, Gerhald LG et al. 2011),  and two homologous RNA structures in the SVR of 
Domain I. The combination of software prediction and RNA phylogeny also 
confirmed four pseudo-knot structures – as reported in the literature (Sztuba-Solinska 
J et al. 2013, Chapman EG et al. 2014A, Piljman GP et al. 2009) and identified a 
novel pseudo-knot structure in the SVR.  
The homologous RNA structures in the SVR exhibited a three-way junction structure 
and a downstream SL structure. The three-way junction structures possess a basal 
stem, a 5’ bulge and a 3’ pseudo-knotted hairpin. To verify the presence of these RNA 
structures in the four serotypes, their RNA secondary structures were constructed 
using as template the consensus 3’ UTR secondary RNA structure (Fig. 22). The 
second (3’) homologous RNA structure was found to differ from one serotype to 
another, exhibiting a 5’ hairpin instead of a bulge in DENV-2. Furthermore, 3’ UTR 
of DENV-4 lacked the first (5’) homologous RNA structure, fully explaining the 
shorter 3’ UTR found in this serotype and suggesting that DENV-4 strains may 







The 3’ UTR RNA secondary structures for each serotype further confirmed the 
presence of novel tertiary RNA interactions in the 3’ UTR of all DENV serotypes, 
including sylvatic DENV isolates (Fig. 23).  
Figure 22. RNA secondary structures of the 3’UTR of four DENV serotypes. 
Conserved nucleotide sites are highlighted according to the nucleotide composition 
(G= Yellow, C=Blue, A=Red and U=Green). Blue arrows indicate the predicted 
sfRNA start site and and the red arrow points the positively selected hairpin in the 3’ 





Chapman et al. (2014A) recently performed the RNA chemical probing of the DENV-
2 3’ UTR, they also identified two homologous RNA structures in the SVR of 
Domain I and described the three-junction RNA structure. Later last year, they 
published (a crystal structure of a homologous three-way junction structure in the 3’ 
UTR of Murray valley encephalitis virus, a flavivirus. They termed this RNA 
structure as “xrRNA” – since it was found to be resistant to degradation by the host 
Xr1 ribonuclease, leading to the production of sfRNA (Chaptman et al 2014B). 
Interestingly, the sequence conservation significantly drops in the few nucleotides 
Figure 23. Tertiary RNA interactions in 3’ UTR of DENV. Four know pseudo-
knots in the 3’UTR have been described. The RNA phylogenetics revealed a novel 
pseudo-knot (Red arrows) in the SVR of the 3’ UTR.  
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immediately before the 5’ xrRNA structure in the four serotypes, as I reported earlier 
(Finol E, 2014). These positions also correspond with the suggested sfRNA start 
(Chapman et al 2014A), indicating the absence of important RNA structures upstream 
to the xrRNA structure and corroborating its relevance for sfRNA production and 
perhaps viral fitness.  
Furthemore, a novel pseudo-knot seems to occur between three bases in the loop in 
the 3’xrRNA downstream SL structure and the three bases immediately upstream the 
DB1 structure (Fig. 23). Even though the RNA chemical probing of DENV-2 3’UTRs 
performed by Chaptman EG, et al. (2014A) does not reveal these interactions, a more 
careful analysis of these RNA probing data might confirm this pseudo-knot. Since the 
two interacting RNA triplets appears to show a higher SHAPE reactivity when probed 
separately as compared to their low reactivity in the full 3’ UTR probing data. A more 
recent SHAPE data from the DENV-2 3’UTR also showed a low reactivity in these 
interacting RNA triplets and further suggests the presence of the novel pseudo-knot 
predicted by RNA phylogeny (Villordo S, et al 2015). However, the existance of 
these interactions and the consequences of their disruption in term of viral fitness still 
remain to be experimentally elucidated. 
Positive selection in the 3’ xrRNA structure of the DENV-2 3’ UTR correlates 
with the molecular evolution of this serotype, suggesting an overriding role of 
this RNA structure on DENV-2 viral fitness. 
To determine whether the RNA structures in the 3’UTR and the sfRNA production 
play a role in the evolution of DENV, selection pressure was examined in a site-by-
site basis in the RNA segment involved in the sfRNA structure using a maximum-
likelihood (ML) method (Wong WS & Nielsen R, 2004). In this approach, the 
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nucleotide substitution rate in each position of the sfRNA sequence was calculated 
and adjusted by the synonymous substitution rate in the coding region of each DENV 
serotype. This ratio models a parameter . When a nucleotide position evolved 
neutrally  = 1 (e.i. equivalent substitutions rates), whereas  > 1 or  < 1 indicate that 
a given position in the non-coding RNA sequence has a higher or lower substitution 
rate than the synonymous substitution rate in the coding region, and thus estimating 
whether this nucleotide position has undergone the action of positive or negative 
selection respectively. Figure 24 shows the  values for each position in the four 
DENV 3’UTR.  A 95% confidence interval of the  parameter along DENV genome 





Figure 24. Natural selection on the 3’UTR of DENV. A maximum-likelihood 
method was applied to detect the action of natural selection in the 3’ UTR of DENV 
in a site-by site basis. A zeta parameter and its 95% CI interval determined whether 
a nucleotide position underwent negative (Blue dots), positive selection (Red dots) 
or neutral evolution (Black dots). 
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Overall, most nucleotide positions depicted a  value lower than 1, some others 
appear to evolve neutrally, slightly over or below 1, and a small set of nucleotide 
positions exhibited a  value higher than 1 in the 3’ UTR of DENV-2. Even though 
these data indicate that sfRNA structures in the four DENV serotypes have 
experienced a strong negative selection, it does not represent a surprising finding 
since a strong purifying selection also characterizes the evolution of the coding region 
of DENV genomes (Holmes EC. 2006). Furthermore, these data correlates with the 
predominant negative selection reported for the 3’UTR of DENV-1 by Wong WS & 
Nielsen R (2004). Remarkably, our data brought to light a segment of 7 nucleotides 
and one base-pairing from the 3’ xrRNA structure of DENV-2 that appear to have 
undergone the action of positive selection (Fig. 24). The seven sites correspond to the 
5’ hairpin in this structure, indicating that substitutions in this RNA segment might 
have been conferring a competitive advantage and its RNA structure might play role 
in dengue-2 viral fitness. 
To further assess the role of the sfRNA structures in the evolution of DENV-2, a ML 
phylogenetic tree was built using a nucleotide substitution model of evolution for non-
coding RNA. This model was based on the sfRNA alignment and consensus sfRNA 
secondary structure of DENV-2. The phylogenetic tree clearly shows that the 
molecular evolution of sfRNA structures also correlates with the known molecular 
evolution of the coding region of DENV-2 genome, exhibiting the clustering of the 
DENV-2 strains into 6 major genotypes (Fig. 25). Remarkably, the positively selected 
hairpin shows substantial differences in nucleotide composition and structure across 
DENV-2 genotypes. In addition, The ML tree also exhibited the segregation of the 
two DENV-2 lineages involved in four clade replacements in Puerto Rico, Nicaragua 








Figure 25. Phylogenetic of DENV-2 based on the 3’ UTR sequences. (A) A 
maximum-likelihood phylogenetic tree from the 3’ UTR of DENV-2 was built using 
PHASE 3.0 software. This software applies a RNA structure based approach to 
construct the Phylogeny of non-coding RNAs. A hairpin in 3’ UTR exhibited distinct 
nucleotide composition and structure in the different DENV-2 genotypes. (B) 
Phylogenetics of the American branch from the SE Asian/American genotype. Major 
clades from Nicaragua (NI) and Puerto Rico (PR) are shown. NI-2B and PR-FD 




Nucleotide substitutions in the 3’ UTR of DENV-2 are associated to 
epidemiological fitness and they regularly map to the 3’ xrRNA structure, 
modifying its minimal free energy and perhaps its protein binding properties. 
To identify the structural location and estimate the structural consequences of the 
nucleotide substitutions in the 3’ UTR of DENV-2 strains involved in the above-
mentioned DENV-2 clade replacements, the 3’UTR RNA secondary structures of the 
two clades was predicted using as template the consensus DENV-2 RNA secondary 
structure and the nucleotides substitution were mapped to the corresponding site (Fig. 
26). 
Two transitional substitutions in the 3’ UTR of the dominant DENV-2 strains in 
1994-1995 Puerto Rico clade replacement mapped to the 5’ xrRNA, one in its very 
first nucleotide and another on the 5’ pseudo-knotted hairpin. A third transitional 
substitution mapped to the loop of the 5’ hairpin of the 3’xrRNA structure. In this 5’ 
hairpin, a transversional substitution (C>A) was also found in the Tonga natural 
attenuation event. Furthermore, two nucleotide substitutions in the dominant 
Nicaragua strains represented a nucleotide base-pair co-variation (A:U>G:C) in the 
stem of the pseudo-knotted hairpin of the 3’ xrRNA structure. Lastly, five transitional 
substitutions in the dominant Singapore DENV-2 clade locate to the 3’xrRNA: two in 
the loop of the 5’ hairpin, one in the stem of the pseudo-knotted hairpin and two 








To further estimate their structural implication, these nucleotide substitutions were 
classified into two types: those substitutions involved in secondary and tertiary base-
pairings and those found in the 5’ loop of the 3’ xrRNA structure. To test whether the 
first groups of substitutions alter the stability of the RNA structure, the minimal free 
Figure 26. Substitution in the 3’ UTR of dominant DENV-2 strains.  Location 
and structural consequences of nucleotide substitution in dominant lineage strains 




energy (mfe) of the RNA structures in both DENV-2 clade were calculated. These 
data clearly show that the substitutions in the 3’ xrRNA reduce the minimal free 
energy of the RNA structures in the dominant strains in Nicaragua (mfe: -1.5 
kcal/mol) and Singapore (mfe: -2.4 kcal/mol), thus increasing their stability and 
promoting their proper folding. These bio-informatics data perfectly match with the 
small increase in sfRNA production that Manokaran G (2014) reported for the 
Nicaragua dominant strains.  
Notably, the dominant Puerto Rico clade contains two transitional substitutions in the 
5’ xrRNA, a structure that appears to play a crucial role in sfRNA production. The 
first substitution may represent a base that interacts with the host ribonucleases, due to 
its location immediately upstream to the base of xrRNA structure. And the second 
substitution seems to alter the pseudo-knot formations. Taken together, these 
nucleotide changes may explain the significant increase of sfRNA production in the 
dominant DENV-2 strains from Puerto Rico (Manokaran G, 2014). This hypothesis 
also correlates with recent experimental data that indicate that the pseudo-knot 
formation by itself does not confer the Xr1 resistance to this RNA structure 
(Chaptman EG et al. 2014), suggesting that the lost of this tertiary interaction would 
not result in a lower sfRNA production. Instead, it might facilitate novel RNA-RNA 






In this regard, the 3D comparative modeling of the homologous 3’ xrRNA structure 
suggests that the nucleotide substitution in its 5’ loop of the dominant DENV-2 strains 
(Puerto Rico, Singapore and Tonga) may alter the binding properties of this hairpin 
(Fig. 27). It appears to represent an exposed motif that may interact with other 
molecules such as proteins, bringing out the different protein binding patterns that 
Manokaran G (2014) found in the two Puerto Rico DENV-2 lineages and the 
competitive advantage that it granted to the dominant strains – the ability to inhibit 
IFN- expression. 
The xrRNA structures allow the production of sfRNA and evolve to increase the 
epidemiological fitness of DENV-2 strains, providing a model of sfRNA 
evolution. 
Taking into account these bio-informatic data and the experimental data provided by 
Manokaran G (2014), a novel model of evolution for the RNA structures in the 3’ 
Figure 27. Tertiary RNA structure of the second Xrn1-resistant structure in 
the 3’ UTR of DENV-2.   2D and 3D structures of the 3’ xrRNA of DENV-2. The 
3D RNA model was built based on the crystallography of the homologous xrRNA 
structure in the Murray Valley Encephalitis virus (Protein Data Bank ID: 4PQV) 
using ModeRNA. The RNA backbone is shown in different colors according to the 
secondary structure. Pseudo-knot (pk2) is highlighted in yellow.  
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UTR of DENV can be proposed. In this model, the 3’SL and DB structures in Domain 
II and III represent highly conserved structures with major functions in DENV 
replication and the two xrRNA structures in the Domain I embody a RNA segment 
frees to evolve, adapt and confer to DENV strains an advantage in the struggle to 
survive in their interspecies transmission. Hence, the 5’ xrRNA structure has less 
evolutionary freedom due to its role in sfRNA production, whereas the 3’xrRNA 
structure has more freedom to evolve and acquire novel RNA interactions and protein 
binding properties. This evolutionary model is strongly supported by the positive 
selection identified in the 3’ xrRNA structure of DENV-2 and handful of 
experimental data, besides the data provided in Manokaran G (2014).   
For instance, Bidet K, et al. (2014) demonstrated that the 3’xrRNA interacts with 
host-proteins, mediating the sfRNA-induced inhibition of ISG translation. These data 
support the proposed evolutionary role for this RNA structure. Previous work also 
indicated that the xrRNA structures in the VR may play distinct functions in the two 
hosts. The deletion of the variable region from the 3’ UTR of a DENV-2 replicon 
depicted a different replication pattern in mammalian cell lines as compared to 
DENV-replicon replication in mosquito cell lines (Alvarez DE et al. 2005). 
Furthermore, other interesting experiments were carried out earlier to compare the 
replicative fitness of two DENV-2 genotypes (Cologna R & Rico-Hesse R. 2003): a 
dominant SE Asian/American genotype versus the American genotype, an 
epidemiologically weaker genotype. In their experiments, they cloned the 3’ UTR of 
the American genotype into a SE Asian/American infectious clone. Interestingly, it 
showed a smaller plaque size in Vero cells and slower growth kinetics in mosquito 
cells as compared to the wild type infectious clone. These findings were further 
validated in similar experiments using human monocytes and dendritic cells. This first 
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set of evidences suggest a fundamental role for nucleotide changes in the 3’ UTR of 
DENV-2 strains with respect to their replicative fitness and further support the 




For a long time, the lack of structural data and RNA structure models of the 3’UTR of 
DENV have hindered the understanding of nucleotide substitutions in non-coding 
regions of DENV viruses. In this study, I take advantage of the complete DENV 
genome sequences that have been deposited into public databases in the last few years 
due to the advances in sequencing methods and applied RNA phylogenetics to 
develop a model of RNA secondary structures for the 3’ untranslated region of each 
serotype of dengue virus. These models allowed the identification of RNA structural 
changes that potentially explain differences in sfRNA production and function, which 
are associated with epidemiological fitness of DENV strains. Furthermore, a model of 
the evolution for this genomic segment is proposed based on the known functions and 
natural selection of the RNA structures, providing the foundations for subsequent 
exploration into the significance of mutations and structural changes in RNA 
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